[1] FLAXMAN SR,BOURNE RRA,RESNIKOFF S,et al.Global causes of blindness and distance vision impairment 1990-2020:a systematic review and meta-analysis[J].Lancet Glob Health,2017,5(12):e1221-e1234.
[2] FALAVARJANI KG,NGUYEN QD.Adverse events and complications associated with intravitreal injection of anti-VEGF agents:a review of literature[J].Eye (Lond),2013,27(7):787-794.
[3] NUZZI R,TRIDICO F.Local and systemic complications after intravitreal administration of anti-vascular endothelial growth factor agents in the treatment of different ocular diseases:a five-year retrospective study[J].Semin Ophthalmol,2015,30(2):129-135.
[4] MACKLIN PS,MCAULIFFE J,PUGH CW,et al.Hypoxia and HIF pathway in cancer and the placenta[J].Placenta,2017,56:8-13.
[5] DEVRAJ G,BEERLAGE C,BRUNE B,et al.Hypoxia and HIF-1 activation in bacterial infections[J].Microbes Infec,2017,19(3):144-156.
[6] FLEISCHER M,KESSLER R,KLAMMER A,et al.LOH on 10p14-p15 targets the PFKFB3 gene locus in human glioblastomas[J].Genes Chromosomes Cancer,2011,50(12):1010-1020.
[7] KESSLER R,ESCHRICH K.Splice isoforms of ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in human brain[J].Brain Res Mol Brain Res,2001,87(2):190-195.
[8] SHI L,PAN H,LIU Z,et al.Roles of PFKFB3 in cancer[J].Signal Transduct Target Ther,2017,2:17044.
[9] HUE L,RIDER MH.Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues[J].Biochem J,1987,245(2):313-324.
[10] OKAR DA,MANZANO A,NAVARRO-SABATE A,et al.PFK-2/FBPase-2:maker and breaker of the essential biofactor fructose-2,6-bisphosphate[J].Trends Biochem Sci,2001,26(1):30-35.
[11] EL-MAGHRABI MR,PILKIS SJ.Rat liver 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase:a review of relationships between the two activities of the enzyme[J].J Cell Biochem,1984,26(1):1-17.
[12] BANDO H,ATSUMI T,NISHIO T,et al.Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer[J].Clin Cancer Res,2005,11(16):5784-5792.
[13] FUKASAWA M,TSUCHIYA T,TAKAYAMA E,et al.Identification and characterization of the hypoxia-responsive element of the human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene[J].J Biochem,2004,136(3):273-277.
[14] OBACH M,NAVARRO-SABATE A,CARO J,et al.6-Phosphofructo-2-kinase (PFKFB3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia[J].J Biol Chem,2004,279(51):53562-53570.
[15] CANTELMO AR,CONRADI LC,BRAJIC A,et al.Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization,impairs metastasis,and improves chemotherapy[J].Cancer Cell,2016,30(6):968-985.
[16] LI X L,LIU J,QIAN L,et al.Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy[J].Mol Cell Biochem,2018,445(1-2):123-134.
[17] MARIN-HERNANDEZ A,GALLARDO-PEREZ JC,RALPH SJ,et al.HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms[J].Mini Rev Med Chem,2009,9(9):1084-1101.
[18] NOVELLASDEMUNT L,BULTOT L,MANZANO A,et al.PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli[J].Biochem J,2013,452(3):531-543.
[19] RODRIGUEZ-GARCIA A,SAMSO P,FONTOVA P,et al.TGF-beta1 targets Smad,p38 MAPK,and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells[J].FEBS J,2017,284(20):3437-3454.
[20] NOVELLASDEMUNT L,OBACH M,MILLAN-ARINO L,et al.Progestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3(PFKFB3) in breast cancer cells[J].Biochem J,2012,442(2):345-356.
[21] SHAW G,KAMEN R.A conserved AU sequence from the 3'untranslated region of GM-CSF mRNA mediates selective mRNA degradation[J].Cell,1986,46(5):659-667.
[22] GE X,LYU P,CAO Z,et al.Overexpression of miR-206 suppresses glycolysis,proliferation and migration in breast cancer cells via PFKFB3 targeting[J].Biochem Biophys Res Commun,2015,463(4):1115-1121.
[23] DU JY,WANG LF,WANG Q,et al.miR-26b inhibits proliferation,migration,invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells[J].Oncol Rep,2015,33(4):1890-1898.
[24] WU Y,ZHANG MH,XUE Y,et al.Effect of microRNA-26a on vascular endothelial cell injury caused by lower extremity ischemia-reperfusion injury through the AMPK pathway by targeting PFKFB3[J].J Cell Physiol,2019,234(3):2916-2928.
[25] IMBERT-FERNANDEZ Y,CLEM BF,O'NEAL J,et al.Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3)[J].J Biol Chem,2014,289(13):9440-9448.
[26] RIERA L,MANZANO A,NAVARRO-SABATE A,et al.Insulin induces PFKFB3 gene expression in HT29 human colon adenocarcinoma cells[J].Biochem Biophys Acta,2002,1589(2):89-92.
[27] YALCIN A,CLEM BF,SIMMONS A,et al.Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases[J].J Biol Chem,2009,284(36):24223-24232.
[28] ALMEIDA A,BOLANOS JP,MONCADA S.E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation[J].Proc Nati Acad Sci U S A,2010,107(2):738-741.
[29] DE BOCK K,GEORGIADOU M,SCHOORS S,et al.Role of PFKFB3-driven glycolysis in vessel sprouting[J].Cell,2013,154(3):651-663.
[30] BIERHANSL L,CONRADI L C,TREPS L,et al.Central role of metabolism in endothelial cell function and vascular disease[J].Physiology,2017,32(2):126-140.
[31] EELEN G,DE ZEEUW P,TREPS L,et al.Endothelial cell metabolism[J].Physiol Rev,2018,98(1):3-58.
[32] PAIK JY,JUNG KH,LEE JH,et al.Reactive oxygen species-driven HIF1alpha triggers accelerated glycolysis in endothelial cells exposed to low oxygen tension[J].Nucl Med Biol,2017,45:8-14.
[33] WRIGHTON KH.Morphogenesis:fuelling vessel sprouting[J].Nat Rev Mol Cell Biol,2013,14(9):544.
[34] FITZGERALD G,SORO-ARNAIZ I,DE BOCK K.The warburg effect in endothelial cells and its potential as an anti-angiogenic target in cancer[J].Front Cell Dev Biol,2018,6:100.
[35] SCHOORS S,DE BOCK K,CANTELMO AR,et al.Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis[J].Cell Metab,2014,19(1):37-48.
[36] SAMANTARAY S,DAS A,MATZELLE DC,et al.Administration of low dose estrogen attenuates persistent inflammation,promotes angiogenesis,and improves locomotor function following chronic spinal cord injury in rats[J].J Neurochem,2016,137(4):604-617.
[37] JIANG CF,LI DM,SHI ZM,et al.Estrogen regulates miRNA expression:implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis[J].Oncotarget,2016,7(24):36940-36955.
[38] TRENTI A,TEDESCO S,BOSCARO C,et al.The glycolytic enzyme PFKFB3 is involved in estrogen-mediated angiogenesis via GPER1[J].J Pharmacol Exp Ther,2017,361(3):398-407.